Lawrence Glad, MD
Obstetrics & Gynecology · Hopwood, PANPI 1750311015
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,000 of the $4,696 with a category attached, or 63.9%. Roche Diagnostics Corporation accounts for 91.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $4,386 and has fallen 99.0% since, to $43 in 2025. Among obstetrics & gynecology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $204.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Diagnostics Corporation$4K
- AbbVie$140
- Coopersurgical, Inc.$87
- Coloplast$39
- Radius Health, Inc.$30
- Minerva Surgical, Inc$29
- plus $93 from 5 others
What the payments were for
- Consulting fees$3,00064%
- Travel & lodging$90619%
- Food & beverage$73616%
- Education$541%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Diagnostics Corporation | 6 | $4,277 |
| AbbVie | 4 | $140 |
| Coopersurgical, Inc. | 2 | $87 |
| Coloplast | 2 | $39 |
| Radius Health, Inc. | 2 | $30 |
| Minerva Surgical, Inc | 2 | $29 |
| Organon | 1 | $25 |
| Pfizer | 1 | $23 |
| Myovant Sciences Inc. | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Covidien LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,696 in reported general payments places this provider in the 90th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 89 | $57,586 |
| ProliaDenosumab | 17 | $27,529 |
| Estradiol | 127 | $7,137 |
| Trospium Chloride ErTrospium Chloride | 34 | $5,427 |
| Tolterodine Tartrate ErTolterodine Tartrate | 40 | $5,361 |
| Risedronate Sodium | 41 | $3,954 |
| Solifenacin Succinate | 74 | $3,862 |
| Estradiol (Twice Weekly)Estradiol | 25 | $2,823 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 61 | $1,647 |
| Raloxifene Hcl | 35 | $1,470 |
| Oxybutynin Chloride ErOxybutynin Chloride | 48 | $1,189 |
| Estradiol (Once Weekly)Estradiol | 16 | $1,167 |
| Clobetasol Propionate | 27 | $942 |
| Norethindrone Acetate | 22 | $347 |
| Tamsulosin Hcl | 11 | $269 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Hopwood
- John SunyeczHopwood$21K
- Stephen KlaskoPhiladelphia$2.2M
- Stephanie SoberPhiladelphia$1.8M
- Barry JacobsonGlen Mills$302K
- Timothy GrubeFrackville$260K
- Russell StankiewiczLewisburg$202K
- Jamille Nagtalon-RamosPhiladelphia$183K
- Timothy DeimlingMechanicsburg$182K
- Gerald HarkinsMechanicsburg$140K
- Kirthik ParthasarathyWest Reading$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.